tiprankstipranks
Mind Medicine (MNMD)
NASDAQ:MNMD

Mind Medicine (MNMD) Financial Statements

968 Followers

Mind Medicine Financial Overview

Mind Medicine's market cap is currently ―. The company's EPS TTM is $-2.45; its P/E ratio is -4.44; Mind Medicine is scheduled to report earnings on May 15, 2024, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jul 23Jun 23Apr 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -23.86M$ -17.92M$ -581.82K-$ -2.07M
EBITDA$ -23.07M$ -17.13M$ -563.90K-$ -2.06M
Net Income Common Stockholders$ -23.86M$ -17.92M$ -575.19K-$ -2.08M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 99.70M$ 117.70M$ 3.97M-$ 5.38M
Total Assets$ 124.54M$ 141.55M$ 4.49M-$ 6.00M
Total Debt$ 14.13M$ 0.00$ 0.00$ 0.00$ 4.94K
Net Debt$ -85.58M$ -117.70M$ -3.97M$ 0.00$ -5.38M
Total Liabilities$ 46.41M$ 45.57M$ 1.66M-$ 2.65M
Stockholders Equity$ 78.13M$ 95.98M$ 2.83M-$ 3.34M
Cash Flow-
Free Cash Flow$ -20.56M$ -16.63M$ -1.38M-$ -54.63K
Operating Cash Flow$ -20.56M$ -16.63M$ -1.38M-$ -54.63K
Investing Cash Flow--$ 7.69K--
Financing Cash Flow$ 2.59M$ 17.40M$ -31.69K-$ 845.49K
Currency in USD

Mind Medicine Earnings and Revenue History

Mind Medicine Debt to Assets

Mind Medicine Cash Flow

Mind Medicine Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis